Printer Friendly

SUMMIT TECHNOLOGY, INC. AGREES TO PURCHASE PATENTS

 WALTHAM, Mass., June 18 /PRNewswire/ -- Summit Technology, Inc. (NASDAQ: BEAM) announced today that it has agreed to acquire, for up to $7 million, certain European, Japanese and United States patents covering apparatus for performing excimer laser corneal surgery. Summit's acquisition of the United States patents is subject to a right of first refusal held by Pillar Point Partners to purchase such U.S. patents for $3 million that is exercisable on or before July 1, 1993.
 Summit Technology, Inc. has established the leadership position in designing, manufacturing and marketing ophthalmic refractive laser systems where applications have been developed for the treatment of common vision disorders such as nearsightedness, farsightedness, astigmatism, glaucoma and certain corneal irregularities due to disease or injury.
 -0- 6/18/93
 /CONTACT: Paula Rainville of Summit Technology, 617-890-1234/
 (BEAM)


CO: Summit Technology, Inc. ST: Massachusetts IN: MTC SU:

DD -- NE002 -- 3424 06/18/93 08:16 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 18, 1993
Words:150
Previous Article:EG&G ALTERS EXPECTATIONS FOR SECOND QUARTER EARNINGS
Next Article:UCSF PATENT ALLOWED FOR TRANSDERMAL DIAGNOSTICS FOR GLUCOSE MONITORING
Topics:


Related Articles
VISX AND SUMMIT REACH PATENT ACCORD
SUMMIT RECEIVES NEW PATENT
SUMMIT WINS PATENT INFRINGEMENT LAWSUIT AGAINST CHIRON TECHNOLAS GMBH AND SCHWIND GMBH
SUMMIT FILES SUIT AGAINST VISX FOR PATENT INFRINGEMENT
SUMMIT PREVAILS IN EUROPEAN PATENT OPPOSITION AGAINST VISX PATENT
SUMMIT PREVAILS IN EUROPEAN PATENT OPPOSITION AGAINST VISX PATENT
Schwind to Pay Summit DM 1.23 Million for Patent Infringement
Pillar Point Partners and LaserSight Incorporated Settle Patent Litigation
Summit and VISX Settle Patent Disputes
Remediation and Technology Agreement Executed with BioGenesis.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters